Skip to main content
Year archive

DIMERIX LIMITED — 2020 filings

All 56 regulatory filings released by DIMERIX LIMITED (DXB) in 2020, sourced directly from the official regulator.

56 Filings
2020 Period
2020 filings (56)
Filing Released Lang
Investor Presentation 31 pages 4.2MB
Regulatory Filings
2020-12-15 English
Second Study to Include DMX-200 in COVID-19 Patients 3 pages 236.4KB
Regulatory Filings
2020-11-29 English
Notification of Expired Options 2 pages 360.5KB
Regulatory Filings
2020-11-15 English
ARDS in COVID-19 Patients Protocol Published 4 pages 241.3KB
Regulatory Filings
2020-11-08 English
Positive Additional Data to Support DMX-200 Development 27 pages 3.6MB
Regulatory Filings
2020-10-26 English
Appendix 2A 15 pages 240.4KB
Regulatory Filings
2020-10-26 English
Secondary Trading Notice Pursuant to Section 708A(5)(e) 1
Regulatory Filings
2020-10-26 English
Quarterly Appendix 4C and Activities Report 8 pages 664.4KB
Regulatory Filings
2020-10-22 English
Receipt of R&D Tax Incentive 2 pages 280.9KB
Regulatory Filings
2020-10-20 English
Shareholder Update 5 pages 543.2KB
Regulatory Filings
2020-10-19 English
DMX-700 Data Demonstrates Effect on Key COPD Receptors 4 pages 335.5KB
Regulatory Filings
2020-10-06 English
Virtual Meeting Voting and Registration Guide 7 pages 461.7KB
Regulatory Filings
2020-09-29 English
CEO's Address to Shareholders 16 pages 973.4KB
Regulatory Filings
2020-09-29 English
AGM Presentation 19 pages 2.5MB
Regulatory Filings
2020-09-29 English
Results of Meeting 3 pages 391.3KB
Regulatory Filings
2020-09-29 English
Amended Constitution 62 pages 618.3KB
Regulatory Filings
2020-09-29 English
Notification of expired Options 2 pages 358.9KB
Regulatory Filings
2020-09-24 English
Positive Top-Line Results in DKD Phase 2 Clinical Study 6 pages 304.2KB
Regulatory Filings
2020-09-13 English
Investor Presentation 27 pages 3.7MB
Regulatory Filings
2020-09-13 English
Trading Halt 2 pages 374.0KB
Regulatory Filings
2020-09-09 English
Dimerix Awarded $1 Million MRFF Funding 6 pages 366.3KB
Regulatory Filings
2020-09-02 English
Annual General Meeting - Notice and Letter to Shareholders 4 pages 839.6KB
Regulatory Filings
2020-08-31 English
Notice of Annual General Meeting/Proxy Form 30 pages 1.2MB
Regulatory Filings
2020-08-31 English
Preliminary Final Report 2 pages 125.9KB
Regulatory Filings
2020-08-26 English
Annual Report to shareholders 74 pages 3.3MB
Regulatory Filings
2020-08-26 English
Appendix 4G and Corporate Governance Statement 17 pages 500.6KB
Regulatory Filings
2020-08-26 English
Positive Top-Line Results in FSGS Phase 2a Clinical Study 5 pages 275.6KB
Regulatory Filings
2020-07-28 English
Investor Presentation 30 pages 3.7MB
Regulatory Filings
2020-07-28 English
Trading Halt 2 pages 374.8KB
Regulatory Filings
2020-07-26 English
Last Patient Completes Dosing in DKD Phase 2 Clinical Study 3 pages 245.3KB
Regulatory Filings
2020-07-23 English
Change in substantial holding 2 pages 457.4KB
Regulatory Filings
2020-07-19 English
Quarterly Appendix 4C and Activities Report 8 pages 483.3KB
Regulatory Filings
2020-07-13 English
DMX-700 Program for COPD Advances 3 pages 236.4KB
Regulatory Filings
2020-07-05 English
Appendix 2A 15 pages 297.0KB
Regulatory Filings
2020-06-28 English
Cleansing Notice 1 page 354.1KB
Regulatory Filings
2020-06-28 English
Dimerix Completes $5.8m Placement 3 pages 258.0KB
Regulatory Filings
2020-06-21 English
Proposed issue of Securities - DXB 5 pages 27.8KB
Regulatory Filings
2020-06-21 English
Trading Halt 2 pages 568.1KB
Regulatory Filings
2020-06-17 English
Last Patient Completes Dosing in FSGS Phase 2 Clinical Study 3 pages 260.5KB
Regulatory Filings
2020-06-16 English
Global REMAP-CAP Platform Trial Protocol To Include DMX-200 5 pages 296.5KB
Regulatory Filings
2020-06-03 English
Investor Presentation 25 pages 3.8MB
Regulatory Filings
2020-06-03 English
Trading Halt 2 pages 374.2KB
Regulatory Filings
2020-06-01 English
Dimerix to Present at NWR Virtual Health Conference 22 pages 2.4MB
Regulatory Filings
2020-04-30 English
Quarterly Appendix 4C and Activities Report 7 pages 460.4KB
Regulatory Filings
2020-04-20 English
R&D Tax Incentive Facility 2 pages 271.9KB
Regulatory Filings
2020-04-02 English
Lapse of Options 2 pages 268.0KB
Regulatory Filings
2020-03-31 English
Dimerix Clinical Studies Update 4 pages 530.9KB
Regulatory Filings
2020-03-17 English
Investor Presentation 32 pages 3.9MB
Regulatory Filings
2020-03-08 English
Dimerix Appoints New DMX-200 Medical Advisory Board 5 pages 243.6KB
Regulatory Filings
2020-03-05 English
DMX-200 Treatment Continued Under TGA Special Access Scheme 3 pages 274.4KB
Regulatory Filings
2020-03-02 English
Half Yearly Report and Accounts 28 pages 1.2MB
Regulatory Filings
2020-02-18 English
Half Year Report and Update 3 pages 278.8KB
Regulatory Filings
2020-02-18 English
Quarterly Commentary & Appendix 4C 6 pages 504.6KB
Regulatory Filings
2020-01-20 English
Biotech Partnering Showcase Conference Presentation 48 pages 4.4MB
Regulatory Filings
2020-01-12 English
Change in substantial holding 2 pages 52.5KB
Regulatory Filings
2020-01-09 English
DMX-200 Clinical Trial Update 3 pages 270.4KB
Regulatory Filings
2020-01-06 English